The House Committee on Energy and Commerce convened a hearing to discuss the federal government’s response to the COVID-19 pandemic. Trump Administration officials from the National Institutes of Health (NIH), the Department of Health and Human Services (HHS), the Food and Drug Administration (FDA), and the Centers for Disease Control and Prevention (CDC) testified about their agency’s efforts to support COVID-19 response through guidance and guidelines, the development and distribution of diagnostic tests, therapeutics, and vaccines, and the procurement of personal protective equipment (PPE).
Members of the Committee focused their questions on the recent spike in cases across the country and the need to continue diagnostic tests after President Trump’s comment to slow down testing. Others questioned the vaccine availability timeline and the use of serology tests. Considerations for reopening schools, and PPE availability were also discussed.